Langtidssikkerheden for Kepivance er ikke fuldt ud evalueret med hensyn til generel overlevelse, progressionsfri overlevelse og sekundære maligniteter.
The long-term safety of Kepivance has not been fully evaluated with respect to overall survival, progression free survival and secondary malignancies.